Crohn's Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

In a recent market analysis, it has been projected that the anti-inflammatory drugs segment is set to witness substantial growth, exhibiting a Compound Annual Growth Rate (CAGR) of 4.6% during the forecasted period. This promising surge in the anti-inflammatory drugs segment is expected to drive the global Crohn's disease market in the coming years.

Anti-Inflammatory Drugs: A Beacon of Hope

The anti-inflammatory drugs category has emerged as the leading sector in the global Crohn's disease market, generating a substantial increase in monetary potential between 2024 and 2031. This segment's impressive growth, with a Compound Annual Growth Rate (CAGR) of 4.2% throughout the evaluation period, is expected to establish it as the most profitable segment within the global Crohn's disease market.

A key driving force behind this robust growth is the lack of a permanent cure for Crohn's disease, leading patients to rely on anti-inflammatory drugs for relief. The rising incidence of inflammatory bowel syndrome, including Crohn's disease and ulcerative colitis, further amplifies the demand for anti-inflammatory drugs like Prednisone, Budesonide, and Budesonide-MMX, as these drugs help manage associated conditions such as inflammation, bacterial infections, diarrhea, and mild pain.

Accessible Distribution Channels Fueling Growth

Manufacturers of Crohn's disease drugs are actively focusing on expanding their distribution networks through retail pharmacies and online portals. These channels provide widespread access to anti-inflammatory drugs and corticosteroids, both with and without prescriptions. Additionally, consumers can take advantage of discounts on bulk purchases through online platforms, enhancing the segment's growth.

Challenges Ahead

Despite the promising growth prospects, challenges persist. In regions like Africa and Nigeria, the low diagnosis rate of inflammatory bowel syndrome and a casual attitude towards treatment duration hinder revenue growth in the anti-inflammatory drugs segment. Moreover, in countries like India and China, some Crohn's disease patients are turning to alternative treatment options such as Ayurveda and Homeopathy, posing a potential hindrance to the segment's progress.

Regional Markets and Collaborations

In North America, the anti-inflammatory drugs segment is expected to be the most lucrative, with the U.S. serving as the largest Crohn's disease market in the region. North America is projected to register a CAGR of 4.3%, closely followed by Europe with a 4.0% Compound Annual Growth Rate in this segment.

Notable collaborations in the field include the agreement between U.S.-based Perriago Company plc and U.K.-based AstraZeneca, involving the divestment of US rights to Entocort®, a treatment for Crohn's disease. AstraZeneca's specialization in Budesonide, an anti-inflammatory drug, aligns with the growing demand for such medications.

The Asia Pacific region is also witnessing a burgeoning market for anti-inflammatory drugs, with leading companies actively raising funds for the development of cost-effective solutions.

As the global Crohn's disease market continues to evolve, the anti-inflammatory drugs segment stands poised to play a pivotal role in enhancing patient care and driving growth within the industry.

Competitive Analysis:

Some of the prominent players in the global market for Crohn's disease treatment are:

Abbvie Inc.
Celgene Corporation
Genetech
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Salix Pharmaceuticals Inc.
Takeda's Pharmaceutical Ltd
Janssen Pharmaceuticals
Biogen
AstraZeneca

Market segmentation

By Drug Type

Anti-inflammatory drugs
Immune system suppressors
Antibiotics
Biologics
Anti-diarrheal
Pain relievers

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

By Region

North America
Latin America
Europe
Asia Pacific
MEA

1. Executive Summary

1.1. Global Crohn's Disease Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Crohn's Disease Treatment Market Outlook, 2018 - 2031

3.1. Global Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Anti-inflammatory drugs
  - 3.1.1.2. Immune system suppressors
  - 3.1.1.3. Antibiotics
  - 3.1.1.4. Biologics
  - 3.1.1.5. Anti-diarrheal
  - 3.1.1.6. Pain relievers
3.2. Global Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospital Pharmacies
  - 3.2.1.2. Retail Pharmacies
  - 3.2.1.3. Online Pharmacies
  - 3.2.1.4. Drug Stores
3.3. Global Crohn's Disease Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Crohn's Disease Treatment Market Outlook, 2018 - 2031

4.1. North America Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Anti-inflammatory drugs
  - 4.1.1.2. Immune system suppressors
  - 4.1.1.3. Antibiotics
  - 4.1.1.4. Biologics
  - 4.1.1.5. Anti-diarrheal
  - 4.1.1.6. Pain relievers
4.2. North America Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospital Pharmacies
  - 4.2.1.2. Retail Pharmacies
  - 4.2.1.3. Online Pharmacies
  - 4.2.1.4. Drug Stores
4.3. North America Crohn's Disease Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Crohn's Disease Treatment Market Outlook, 2018 - 2031

5.1. Europe Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Anti-inflammatory drugs
  - 5.1.1.2. Immune system suppressors
  - 5.1.1.3. Antibiotics
  - 5.1.1.4. Biologics
  - 5.1.1.5. Anti-diarrheal
  - 5.1.1.6. Pain relievers
5.2. Europe Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospital Pharmacies
  - 5.2.1.2. Retail Pharmacies
  - 5.2.1.3. Online Pharmacies
  - 5.2.1.4. Drug Stores
5.3. Europe Crohn's Disease Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Crohn's Disease Treatment Market Outlook, 2018 - 2031

6.1. Asia Pacific Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Anti-inflammatory drugs
  - 6.1.1.2. Immune system suppressors
  - 6.1.1.3. Antibiotics
  - 6.1.1.4. Biologics
  - 6.1.1.5. Anti-diarrheal
  - 6.1.1.6. Pain relievers
6.2. Asia Pacific Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospital Pharmacies
  - 6.2.1.2. Retail Pharmacies
  - 6.2.1.3. Online Pharmacies
  - 6.2.1.4. Drug Stores
6.3. Asia Pacific Crohn's Disease Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Crohn's Disease Treatment Market Outlook, 2018 - 2031

7.1. Latin America Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Anti-inflammatory drugs
  - 7.1.1.2. Immune system suppressors
  - 7.1.1.3. Antibiotics
  - 7.1.1.4. Biologics
  - 7.1.1.5. Anti-diarrheal
  - 7.1.1.6. Pain relievers
7.2. Latin America Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Hospital Pharmacies
  - 7.2.1.2. Retail Pharmacies
  - 7.2.1.3. Online Pharmacies
  - 7.2.1.4. Drug Stores
7.3. Latin America Crohn's Disease Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Crohn's Disease Treatment Market Outlook, 2018 - 2031

8.1. Middle East & Africa Crohn's Disease Treatment Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Anti-inflammatory drugs
  - 8.1.1.2. Immune system suppressors
  - 8.1.1.3. Antibiotics
  - 8.1.1.4. Biologics
  - 8.1.1.5. Anti-diarrheal
  - 8.1.1.6. Pain relievers
8.2. Middle East & Africa Crohn's Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospital Pharmacies
  - 8.2.1.2. Retail Pharmacies
  - 8.2.1.3. Online Pharmacies
  - 8.2.1.4. Drug Stores
8.3. Middle East & Africa Crohn's Disease Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Nigeria Crohn's Disease Treatment Market Distribution Channel, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Crohn's Disease Treatment Market by Drug Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.11. Rest of Middle East & Africa Crohn's Disease Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Drug Type vs Distribution Channel Heatmap
9.2. Manufacturer vs Distribution Channel Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Allergan, Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Drug Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. UCB S.A.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Drug Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. AbbVie Inc.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Drug Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Perrigo Company plc
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Drug Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Takeda Pharmaceutical Company Limited
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Drug Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Johnson & Johnson Services, Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Drug Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Bayer AG
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Drug Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Ferring B.V.
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Drug Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations